Myung Pharma Shares Slip 1.2% Amid Broader Korean Pharma Decline – What Investors Need to Know
Myung Pharma slips 1.2% amid steady earnings; see how it stacks against peers Gs P&L and Innocean Worldwide and why the 200‑day MA matters.
- MYUNG in PHARMA CO LTD
- Korea, Republic Of
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read